Successful reduction of alopecia induced by anthracycline and taxane containing adjuvant chemotherapy in breast cancer – clinical evaluation of sensor-controlled scalp cooling

SpringerPlus

Volumn 3, Issue 1, 2014, Pages

  Friedrichs, Kay ^a   Carstensen, Martin H ^a  

^a Jerusalem Hospital   (Germany)

Author keywords

Adjuvant chemotherapy; Alopecia; Breast cancer; Scalp cooling

Indexed keywords

EID: 84907190427     PISSN: None     EISSN: 21931801     Source Type: Journal    
DOI: 10.1186/2193-1801-3-500     Document Type: Article

References (17)

1. AGO e.V: Guidelines of the AGO Breast Committee, Version 13.1.0, 2013. http://www.ago-online.de/en/guidelines-mamma/march-2014/, Access on March 4th, 2014
2. Batchelor D: Hair and cancer chemotherapy: consequences and nursing care –a literature study.Eur J Cancer Care (Engl) 2001,10(3):147–163. 10.1046/j.1365-2354.2001.00272.x
3. Breed WP, Van den Hurk CJ, Peerbooms M: Presentation, impact and prevention of chemotherapy-induced hair loss: scalp cooling potentials and limitations.Expert Rev Dermatol 2011, 6:109–125. 10.1586/edm.10.76
4. Connie HY, Margaret HF, Michelle G (Eds): Cancer Symptom Management. 3rd edition. Jones and Bartlett Publishers Inc, Sudbury, US; 2004.
5. Dean JC, Salmon SE, Griffith KS: Prevention of doxorubicin-induced hair loss with scalp hypothermia.NEJM 1979,301(26):1427–1429. 10.1056/NEJM197912273012605
6. Katakunnel J, Berger AM: Hair loss. In Cancer: Principles & Practice of Oncology. 8th edition. PA, USA: Lippincott Williams & Wilkins; 2008:2688–2691.
7. Komen MMC, Smorenburg CH, Van den Hurk CJG, Nortier JWR: Factor influencing the effectiveness of scalp cooling in the prevention of chemotherapie-induced alopecia.Oncologist 2013, 18:885–891. 10.1634/theoncologist.2012-0332
8. Massey CS: A multicentre study to determine the efficacy and patient acceptability of the Paxman Scalp Cooler to prevent hair loss in patients receiving chemotherapy.Eur J Oncol Nurs 2004, 8:121–130. 10.1016/j.ejon.2003.10.006
9. Middleton J, Franks D, Buchanan RB, Hall V, Smallwood J, Williams CJ: Failure of scalp hypothermia to prevent hair loss when cyclophosphamide is added to doxorubicin and vincristine.Cancer Treat Rep 1985, 69:373–375.
10. Mols F, Van den Hurk CJ, Vingerhoets AJ, Breed WPM: Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations.Support Care Cancer 2009, 17:181–189. 10.1007/s00520-008-0475-4
11. Prevezas C, Matard B, Pinquier L, Reygagne P: lrreversible end sevcre alopecie following docetaxel or paclitaxel cytotoxic therapy for breast cencer.Br J Dermatol 2009,160(4):883–885. 10.1111/j.1365-2133.2009.09043.x
12. Rugo HS, Serrurier K, Melisko M, Glencer A, Hwang J, D’Agostino R JR, Hutchens S, Esserman L, Melin S: Use of the DigniCap™ System to Prevent Hair Loss in Women Receiving Chemotherapy for Stage I Breast Cancer. BCC, St Gallen; 2013.
13. Tollenaar RAEM, Liefers GJ, Van Driel OJ, Van de Velde CJ: Scalp cooling has no place in the prevention of alopecia in adjuvant chemotherapy for breast cancer.Eur J Cancer 1994, 30a:1448–1453.
14. Van den Hurk CJG, Mols F, Vingerhoets AJJM, Breed WPM: Impact of alopecia and scalp cooling on the well-being of breast cancer patients.Psychooncology 2010,19(7):701–709.
15. Van den Hurk CJG, Peerbooms M, van de Poll-Franse LV, Nortier JW, Coebergh JWW, Breed WP: Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients – results of the Dutch scalp cooling registry.Acta Oncol 2012, 51:497–504. 10.3109/0284186X.2012.658966
16. Van den Hurk CJG, Van den Akker-van Marle ME, Breed WPM, Van de Poll-Franse LV, Nortier JWR, Coebergh JWW: Impact of scalp cooling on chemotherapy-induced alopecia, wig use and hair growth of patients with cancer.Eur J Oncol Nurs 2013,17(5):536–540. 10.1016/j.ejon.2013.02.004
17. World Health Organisation: Handbook for Reporting Results of Cancer Treatment. WHO Offset Publ, Geneva; 1979.